KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Neogenomics (NEO) Net Margin: 2009-2025

Historic Net Margin for Neogenomics (NEO) over the last 17 years, with Sep 2025 value amounting to -14.45%.

  • Neogenomics' Net Margin fell 390.00% to -14.45% in Q3 2025 from the same period last year, while for Sep 2025 it was -16.00%, marking a year-over-year decrease of 393.00%. This contributed to the annual value of -11.92% for FY2024, which is 295.00% up from last year.
  • As of Q3 2025, Neogenomics' Net Margin stood at -14.45%, which was up 41.91% from -24.87% recorded in Q2 2025.
  • Over the past 5 years, Neogenomics' Net Margin peaked at -8.91% during Q4 2024, and registered a low of -42.17% during Q1 2022.
  • Its 3-year average for Net Margin is -14.84%, with a median of -14.45% in 2025.
  • Its Net Margin has fluctuated over the past 5 years, first tumbled by 4,545bps in 2021, then spiked by 1,973bps in 2023.
  • Neogenomics' Net Margin (Quarterly) stood at -33.21% in 2021, then soared by 1,686bps to -16.36% in 2022, then skyrocketed by 715bps to -9.21% in 2023, then increased by 30bps to -8.91% in 2024, then crashed by 390bps to -14.45% in 2025.
  • Its Net Margin stands at -14.45% for Q3 2025, versus -24.87% for Q2 2025 and -15.43% for Q1 2025.